Harmony Biosciences Holdings, Inc. (HRMY) Profit Margins
Over the twelve months to 2026-06-30, Harmony Biosciences Holdings, Inc. (HRMY) had gross margin 75.4%, operating margin 24.0%, net margin 18.9%, free cash flow margin 37.0%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
HRMYHarmony Biosciences Holdings, Inc.Follow HRMY — free
—
Price chart with a free account
- Market cap
- 2.1B
- P/E TTM
- 11.7
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
| Line | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 82.6% | 81.8% | 80.9% | 79.2% | 78.1% | 77.2% | 75.4% | |
| Operating margin | 10.6% | 28.7% | 27.4% | 33.0% | 26.7% | 24.0% | 24.0% | |
| Net margin | -23.1% | 11.3% | 41.4% | 22.1% | 20.4% | 18.3% | 18.9% | |
| FCF margin | -1.9% | 32.2% | 33.0% | 37.6% | 30.6% | 40.1% | 37.0% |
USD billions · SEC XBRL
Harmony Biosciences Holdings, Inc. — questions
- What is Harmony Biosciences Holdings, Inc.'s gross margin?
- 75.4% over the twelve months to 2026-06-30.
- What is Harmony Biosciences Holdings, Inc.'s operating margin?
- 24.0% over the twelve months to 2026-06-30.
- What is Harmony Biosciences Holdings, Inc.'s net profit margin?
- 18.9% over the twelve months to 2026-06-30.
Every figure on this page comes from Harmony Biosciences Holdings, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.